Hodgkin's disease with a mediastinal mass greater than 10 cm: Results of four different treatment approaches

Keyphrases

• 3-year Survival 33%
• 6-cycles 33%
• B Symptoms 33%
• B-stage 33%
• Background Management 33%
• Bleomycin 33%
• Chemotherapy 33%
• Complete Remission 66%
• Cyclophosphamide 33%
• Decarbazine 33%
• Doxorubicin 66%
• Hodgkin Disease 100%
• Intensive Chemotherapy 33%
• Lomustine 33%
• Mediastinal Adenopathy 100%
• Mediastinal Mass 100%
• Mitoxantrone 33%
• Nodal Involvement 33%
• Prednisone 66%
• Procarbazine 66%
• Progression Rate 33%
• Radiation Therapy 33%
• Stage IV Disease 33%
• Treatment Regimen 33%
• Treatment Strategy 100%
• Tumor 33%
• Vinblastine 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Bleomycin 33%
• Chemotherapy 66%
• Cyclophosphamide 33%
• Dacarbazine 33%
• Diseases 66%
• Doxorubicin 66%
• Hodgkin Disease 100%
• Lomustine 33%
• Lymphadenopathy 100%
• Mediastinum Mass 100%
• Mitoxantrone 33%
• Neoplasm 33%
• Prednisone 66%
• Procarbazine 66%
• Remission 66%
• Vinblastine 33%
• Vincristine 66%

Medicine and Dentistry

• B Symptoms 33%
• Bleomycin 33%
• Cyclophosphamide 33%
• Dacarbazine 33%
• Diseases 66%
• Doxorubicin 66%
• Hodgkin's Lymphoma 100%
• Lomustine 33%
• Lymphadenopathy 100%
• Mediastinum Mass 100%
• Mitoxantrone 33%
• Neoplasm 33%
• Prednisone 66%
• Procarbazine 66%
• Radiation Therapy 33%
• Spontaneous Remission 33%
• Vinblastine 33%
• Vincristine 66%